The impact of vildagliptin on the daily glucose profle and coronary plaque stability in impaired glucose tolerance patients with coronary artery disease: VOGUE—A multicenter randomized controlled trial

Reduced Mortality With Ondansetron Use in SARS-CoV2-Infected Inpatients

Comparative clinical study evaluating the effect of adding vildagliptin versus glimepiride to ongoing metformin therapy on diabetic patients with symptomatic coronary artery disease (CAD)

Effect of Amlodipine in Stroke and Myocardial Infarction (MI): A Systematic Review and Meta-analysis

Effects of dapagliflozin on major adverse kidney and cardiovascular (CV) events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial

Omeprazole vs Famotidine for the prevention of gastroduodenal injury in high-risk users of low-dose aspirin: A randomized controlled trial

Dapagliflozin does not increase risk of severe UTIs or acute liver injury

Ondansetron for Shivering after Spinal Anesthesia in Cesarean Delivery: A Systematic Review and Meta-Analysis

Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomized trial